相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。T-705 (Favipiravir) Inhibition of Arenavirus Replication in Cell Culture
Michelle Mendenhall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Influence of Mutagenesis and Viral Load on the Sustained Low-Level Replication of an RNA Virus
Celia Perales et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
An interfering activity against lymphocytic choriomeningitis virus replication associated with enhanced mutagenesis
Veronica Martin et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Structure of Foot-and-Mouth Disease Virus Mutant Polymerases with Reduced Sensitivity to Ribavirin
Cristina Ferrer-Orta et al.
JOURNAL OF VIROLOGY (2010)
Lethal Mutagenesis: Targeting the Mutator Phenotype in Cancer
Edward J. Fox et al.
SEMINARS IN CANCER BIOLOGY (2010)
A Multi-Step Process of Viral Adaptation to a Mutagenic Nucleoside Analogue by Modulation of Transition Types Leads to Extinction-Escape
Ruben Agudo et al.
PLOS PATHOGENS (2010)
Stochastic extinction of viral infectivity through the action of defectors
J. Iranzo et al.
EPL (2009)
Arenavirus genetic diversity and its biological implications
Sebastien F. Emonet et al.
INFECTION GENETICS AND EVOLUTION (2009)
Effect of Ribavirin on the Mutation Rate and Spectrum of Hepatitis C Virus In Vivo
Jose M. Cuevas et al.
JOURNAL OF VIROLOGY (2009)
Potential Benefits of Sequential Inhibitor-Mutagen Treatments of RNA Virus Infections
Celia Perales et al.
PLOS PATHOGENS (2009)
Genetic Detection and Characterization of Lujo Virus, a New Hemorrhagic Fever-Associated Arenavirus from Southern Africa
Thomas Briese et al.
PLOS PATHOGENS (2009)
Molecular strategies to inhibit the replication of RNA viruses
Pieter Leyssen et al.
ANTIVIRAL RESEARCH (2008)
Therapeutically targeting RNA viruses via lethal mutagenesis
Jason D. Graci et al.
FUTURE VIROLOGY (2008)
Naturally Occurring Dominant Resistance Mutations to Hepatitis C Virus Protease and Polymerase Inhibitors in Treatment-Naive Patients
Thomas Kuntzen et al.
HEPATOLOGY (2008)
Effects of introduction of hydrophobic group on ribavirin base on mutation induction and anti-RNA viral activity
Kei Moriyama et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Determinants of RNA-Dependent RNA Polymerase (In) fidelity Revealed by Kinetic Analysis of the Polymerase Encoded by a Foot-and-Mouth Disease Virus Mutant with Reduced Sensitivity to Ribavirin
Armando Arias et al.
JOURNAL OF VIROLOGY (2008)
A new arenavirus in a cluster of fatal transplant-associated diseases
Gustavo Palacios et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Treatment of Late Stage Disease in a Model of Arenaviral Hemorrhagic Fever: T-705 Efficacy and Reduced Toxicity Suggests an Alternative to Ribavirin
Brian B. Gowen et al.
PLOS ONE (2008)
Inhibition of cellular entry of lymphocytic choriomeningitis virus by amphipathic DNA polymers
Andrew M. Lee et al.
VIROLOGY (2008)
No evidence of selection for mutational robustness during lethal mutagenesis of lymphocytic choriomeningitis virus
Veronica Martin et al.
VIROLOGY (2008)
Naturally occurring NS3-protease-inhibitor resistant mutant A156T in the liver of an untreated chronic hepatitis C patient
Maria Cubero et al.
VIROLOGY (2008)
Dehydroepiandrosterone, epiandrosterone and synthetic derivatives inhibit Junin virus replication in vitro
Eliana G. Acosta et al.
VIRUS RESEARCH (2008)
Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naive populations and associate with reduced treatment efficacy
Jeffrey A. Johnson et al.
PLOS MEDICINE (2008)
Analysis of ribavirin mutagenicity in human hepatitis C virus infection
Stephane Chevaliez et al.
JOURNAL OF VIROLOGY (2007)
Mutation rate of the hepatitis C virus NS5B in patients undergoing treatment with ribavirin monotherapy
Glen Lutchman et al.
GASTROENTEROLOGY (2007)
Foot-and-mouth disease virus mutant with decreased sensitivity to ribavirin:: Implications for error catastrophe
Macarena Sierra et al.
JOURNAL OF VIROLOGY (2007)
Phylogeny and evolution of old world arenaviruses
Sebastien Emonet et al.
VIROLOGY (2006)
Transmission of lymphocytic choriomeningitis virus by organ transplantation.
Staci A. Fischer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The anti-yellow fever virus activity of ribavirin is independent of error-prone replication
P Leyssen et al.
MOLECULAR PHARMACOLOGY (2006)
Mechanisms of action of ribavirin against distinct viruses
JD Graci et al.
REVIEWS IN MEDICAL VIROLOGY (2006)
Mutagenic effects of ribavirin and response to interferon/ribavirin combination therapy in chronic hepatitis C
Y Asahina et al.
JOURNAL OF HEPATOLOGY (2005)
Mutagenesis-induced, large fitness variations with an invariant arenavirus consensus genomic nucleotide sequence
A Grande-Pérez et al.
JOURNAL OF VIROLOGY (2005)
Combination of a mutagenic agent with a reverse transcriptase inhibitor results in systematic inhibition of HIV-1 infection
N Tapia et al.
VIROLOGY (2005)
Suppression of viral infectivity through lethal defection
A Grande-Pérez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Ribavirin resistance in hepatitis C virus replicon-containing cell lines conferred by changes in the cell line or mutations in the replicon RNA
JK Pfeiffer et al.
JOURNAL OF VIROLOGY (2005)
The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase
P Leyssen et al.
JOURNAL OF VIROLOGY (2005)
Preextinction viral RNA can interfere with infectivity
C González-López et al.
JOURNAL OF VIROLOGY (2004)
Inhibition of subgenomic hepatitis C virus RNA in Huh-7 cells: ribavirin induces mutagenesis in HCV RNA
T Kanda et al.
JOURNAL OF VIRAL HEPATITIS (2004)
Viral error catastrophe by mutagenic nucleosides
JP Anderson et al.
ANNUAL REVIEW OF MICROBIOLOGY (2004)
Evidence for quasispecies distributions in the human hepatitis A virus genome
G Sánchez et al.
VIROLOGY (2003)
Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis
A Airaksinen et al.
VIROLOGY (2003)
The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA
SF Zhou et al.
VIROLOGY (2003)
Mutagenesis versus inhibition in the efficiency of extinction of foot-and-mouth disease virus
N Pariente et al.
JOURNAL OF VIROLOGY (2003)
Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV)
CM Ruiz-Jarabo et al.
VIROLOGY (2003)
Ribavirin causes error catastrophe during Hantaan virus replication
WE Severson et al.
JOURNAL OF VIROLOGY (2003)
Molecular indetermination in the transition to error catastrophe:: Systematic elimination of lymphocytic choriomeningitis virus through mutagenesis does not correlate linearly with large increases in mutant spectrum complexity
A Grande-Pérez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system
AM Contreras et al.
JOURNAL OF VIROLOGY (2002)
Initiation of HAART in drug-naive HIV type 1 patients prevents viral breakthrough for a median period of 35.5 months in 60% of the patients
K Van Vaerenbergh et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2002)
Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen
V Le Moing et al.
AIDS (2002)
Monitoring of clinical and laboratory data in two cases of imported Lassa fever
H Schmitz et al.
MICROBES AND INFECTION (2002)
Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin
D Maag et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Ribavirin induces error-prone replication of GB virus B in primary tamarin hepatocytes
RE Lanford et al.
JOURNAL OF VIROLOGY (2001)
RNA virus error catastrophe: Direct molecular test by using ribavirin
S Crotty et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Combination of interferon and ribavirin in chronic hepatitis C: Re-treatment of nonresponders to interferon
AM Di Bisceglie et al.
HEPATOLOGY (2001)
Interferon and ribavirin vs interferon alone in the re-treatment of chronic hepatitis C previously nonresponsive to interferon - A meta-analysis of randomized trials
KJ Cummings et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen
S Crotty et al.
NATURE MEDICINE (2000)
Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells
I Jordan et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
分享论文
